Page last updated: 2024-08-24

valsartan and benidipine

valsartan has been researched along with benidipine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akizuki, O; Inayoshi, A; Kitayama, T; Kusaka, H; Matsubara, M; Sasaki, K; Shirakura, S; Yao, K1
Hu, Z; Jiang, B; Li, X; Peng, T; Xia, Q; Yang, X1
Guo, L; Hu, Z; Jiang, B; Li, XH; Pei, F; Peng, T; Song, J; Xia, Q; Yang, XD1

Trials

2 trial(s) available for valsartan and benidipine

ArticleYear
A comparative study of the renoprotective effects of benidipine and valsartan in primary hypertensive patients with proteinuria.
    Arzneimittel-Forschung, 2009, Volume: 59, Issue:12

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Proteinuria; Renal Circulation; Tetrazoles; Valine; Valsartan

2009
[Renal protective effects of benidipine and valsartan in primary hypertension patients with proteinuria].
    Zhonghua xin xue guan bing za zhi, 2010, Volume: 38, Issue:1

    Topics: Adult; Aged; Angiotensin Receptor Antagonists; Calcium Channel Blockers; Dihydropyridines; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Proteinuria; Tetrazoles; Valine; Valsartan

2010

Other Studies

1 other study(ies) available for valsartan and benidipine

ArticleYear
Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    European journal of pharmacology, 2008, Apr-28, Volume: 584, Issue:2-3

    Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Line; Cytochrome P-450 CYP11B2; Dihydropyridines; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; Membrane Potentials; Patch-Clamp Techniques; Potassium Chloride; RNA, Messenger; Steroid 11-beta-Hydroxylase; Tetrazoles; Valine; Valsartan

2008